United States Non Invasive Prenatal Testing(NIPT) Market Size, Market Share, Insights, Growth, Trends, Opportunities, Key Players, Competitive Analysis and Forecast 2023 to 2031
The non-invasive prenatal testing (NIPT) market in the United States is expected to reach USD 2,653 million by 2031. The market is expected to register a CAGR of more than 13% in the forecast period.
The growth of the market depends on several factors, including the increase in the incidence of chromosomal aneuploidies in fetuses, the progress of advanced non-invasive prenatal testing products, the increasing acceptance of non-invasive prenatal testing, the growing focus on reimbursement for non-invasive prenatal testing, the rising preference for non-invasive techniques over invasive methods, and the ACOG guidelines recommending NIPT for all pregnancies regardless of risk.
The report on the non-invasive prenatal testing (NIPT) market in the United States is a comprehensive study and presentation of drivers, restraints, opportunities, demand, market size, insights, forecasts, and trends in the non-invasive prenatal testing (NIPT) market in the United States during 2019 - 2031. Furthermore, the report includes historic market data from 2019 to 2022 and forecast until 2031.
This Well-Versed and Comprehensive United States Non-Invasive Prenatal Testing (NIPT) Market Research Report 2023 is Divided into 14 Chapters:
Chapter 1 contains a brief description of the market under study
Chapter 2 describes the research methodology of the study
Chapter 3 identifies key trends and prospects for the U.S. non-invasive prenatal testing (NIPT) market and draws key conclusions
Chapter 4 analysis of average risk and high-risk non–invasive prenatal testing volume (number of tests performed) and projection through 2031
Chapter 5 evaluates the potential number of NIPT tests performed in the United States with eight years forecast
Chapter 6 discusses the market scenario for non-invasive prenatal testing (NIPT) in the United States in terms of historical market values and projections through 2031
Chapter 7 assessment of market potential and opportunities for this innovation-driven united states non–invasive prenatal testing market with eight years forecast
Chapter 8 highlights key market dynamics in the U.S. NIPT tests market, including factors driving the market, prevailing barriers, potential opportunities, and future trends. This section also includes an analysis of the impact of the driving and restraining factors
Chapter 9 includes a comprehensive analysis of 7 non–invasive prenatal testing comparative analysis
Chapter 10 characteristics of reimbursement structures in the non–invasive prenatal testing market in the United States
Chapter 11 detailed insights into the regulatory framework of the U.S. non–invasive prenatal testing market
Chapter 12 tracks competitive developments, approaches, recent industry developments, and mergers and acquisitions, collaboration, venture capital investment, distribution, exclusivity, partnership and licensing agreements.
Chapter 13 provides the industry landscape and detailed profiles of key companies operating in the non–invasive prenatal testing market in the United States. The companies have been profiled based on their key facts, business description, products and services, current NIPT test portfolio, and key developments.
Chapter 14 i.e. the appendix contains a brief overview of the company, a glossary, contact information, and the disclaimer section.
Key Players in the United States Non–Invasive Prenatal Testing Market are Listed Below:
The growth of the market depends on several factors, including the increase in the incidence of chromosomal aneuploidies in fetuses, the progress of advanced non-invasive prenatal testing products, the increasing acceptance of non-invasive prenatal testing, the growing focus on reimbursement for non-invasive prenatal testing, the rising preference for non-invasive techniques over invasive methods, and the ACOG guidelines recommending NIPT for all pregnancies regardless of risk.
The report on the non-invasive prenatal testing (NIPT) market in the United States is a comprehensive study and presentation of drivers, restraints, opportunities, demand, market size, insights, forecasts, and trends in the non-invasive prenatal testing (NIPT) market in the United States during 2019 - 2031. Furthermore, the report includes historic market data from 2019 to 2022 and forecast until 2031.
This Well-Versed and Comprehensive United States Non-Invasive Prenatal Testing (NIPT) Market Research Report 2023 is Divided into 14 Chapters:
Chapter 1 contains a brief description of the market under study
Chapter 2 describes the research methodology of the study
Chapter 3 identifies key trends and prospects for the U.S. non-invasive prenatal testing (NIPT) market and draws key conclusions
Chapter 4 analysis of average risk and high-risk non–invasive prenatal testing volume (number of tests performed) and projection through 2031
Chapter 5 evaluates the potential number of NIPT tests performed in the United States with eight years forecast
Chapter 6 discusses the market scenario for non-invasive prenatal testing (NIPT) in the United States in terms of historical market values and projections through 2031
Chapter 7 assessment of market potential and opportunities for this innovation-driven united states non–invasive prenatal testing market with eight years forecast
Chapter 8 highlights key market dynamics in the U.S. NIPT tests market, including factors driving the market, prevailing barriers, potential opportunities, and future trends. This section also includes an analysis of the impact of the driving and restraining factors
Chapter 9 includes a comprehensive analysis of 7 non–invasive prenatal testing comparative analysis
Chapter 10 characteristics of reimbursement structures in the non–invasive prenatal testing market in the United States
Chapter 11 detailed insights into the regulatory framework of the U.S. non–invasive prenatal testing market
Chapter 12 tracks competitive developments, approaches, recent industry developments, and mergers and acquisitions, collaboration, venture capital investment, distribution, exclusivity, partnership and licensing agreements.
Chapter 13 provides the industry landscape and detailed profiles of key companies operating in the non–invasive prenatal testing market in the United States. The companies have been profiled based on their key facts, business description, products and services, current NIPT test portfolio, and key developments.
Chapter 14 i.e. the appendix contains a brief overview of the company, a glossary, contact information, and the disclaimer section.
Key Players in the United States Non–Invasive Prenatal Testing Market are Listed Below:
- Illumina, Inc.
- Natera, Inc.
- Quest Diagnostics
- Myriad Genetics, Inc.
- Centogene
- GenPath
- PerkinElmer
- Yourgene Health
- Invitae Corporation
- Agilent Technologies
- Ariosa Diagnostics (Roche)
- Laboratory Corporation of America Holdings(Labcorp)
- What is the current scenario of the non-invasive prenatal testing market in the United States?
- What is the total market size for non-invasive prenatal testing in the United States and what are the projections (through 2031) for this market?
- How large is the market for noninvasive prenatal testing in the United States?
- Which is the top non-invasive prenatal test available in the united states?
- How has the potential market performed so far and how will it perform in the coming years?
- How many NIPT tests are being performed in the united states during 2019 – 2031?
- What is the market size of the average risk NIPT tests in the united states?
- What is the market size of the high-risk NIPT tests in the united states?
- What are the key marketed NIPT tests available in the united states?
- What are the major drivers of the united states non–invasive prenatal testing market?
- What are the major inhibitors of the united states non–invasive prenatal testing market?
- What is the reimbursement pattern in the united states non–invasive prenatal testing market?
- What is the regulatory framework in the united states non–invasive prenatal testing market?
- What are the major deals and agreement happenings in the united states non–invasive prenatal testing market?
- What companies offer NIPT tests in the united states?
- Who are the top market players? What are their happenings, current developments, and scenarios?
- How is the market predicted to develop in the future?
- What is the degree of competition in the industry?
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. UNITED STATES ACTUAL NON–INVASIVE PRENATAL TESTING VOLUME (NUMBER OF TESTS PERFORMED) AND FORECAST (2019 - 2031)
4.1 Average Risk Actual NIPT Test Volume (Number of Tests Performed) and Forecast
4.2 High-Risk Actual NIPT Test Volume (Number of Tests Performed) and Forecast
5. UNITED STATES POTENTIAL NON–INVASIVE PRENATAL TESTING VOLUME (NUMBER OF TESTS PERFORMED) AND FORECAST (2019 - 2031)
5.1 Average Risk Potential NIPT Test Volume (Number of Tests Performed) and Forecast
5.2 High-Risk Potential NIPT Test Volume (Number of Tests Performed) and Forecast
6. UNITED STATES ACTUAL NON–INVASIVE PRENATAL TESTING MARKET SIZE AND FORECAST (2019 - 2031)
6.1 Average Risk Actual NIPT Test Market Size and Forecast
6.2 High-Risk Actual NIPT Test Market Size and Forecast
7. UNITED STATES POTENTIAL NON–INVASIVE PRENATAL TESTING MARKET SIZE AND FORECAST (2019 - 2031)
7.1 Average Risk Potential NIPT Test Market Size and Forecast
7.2 High-Risk Potential NIPT Test Market Size and Forecast
8. UNITED STATES NON–INVASIVE PRENATAL TESTING MARKET GROWTH DRIVERS AND CHALLENGES
8.1 Key Market Growth Drivers
8.2 Key Market Challenges
9. NON–INVASIVE PRENATAL TESTING COMPARATIVE ANALYSIS
10. REIMBURSEMENT ENVIRONMENT OF THE UNITED STATES NON-INVASIVE PRENATAL TESTING
11. REGULATION FRAMEWORK OF THE UNITED STATES NON-INVASIVE PRENATAL TESTING
12. MAJOR DEALS AND AGREEMENTS IN THE NON–INVASIVE PRENATAL TESTING MARKET
12.1 Collaboration Deals
12.2 Venture Capital Investment
12.3 Mergers and Acquisitions
12.4 Exclusive Agreement
12.5 Licensing Agreement
12.6 Distribution Agreement
12.7 Partnership Deals
13. KEY COMPANIES ANALYSIS
13.1 Laboratory Corporation of America Holdings
13.1.1 Business Overview
13.1.2 Product Outlook
13.1.3 Key Developments
13.2 Yourgene Health
13.2.1 Business Overview
13.2.2 Product Outlook
13.2.3 Key Developments
13.3 Ariosa Diagnostics (Roche)
13.3.1 Business Overview
13.3.2 Product Outlook
13.3.3 Key Developments
13.4 Illumina, Inc.
13.4.1 Business Overview
13.4.2 Product Outlook
13.4.3 Key Developments
13.5 Natera,Inc.
13.5.1 Business Overview
13.5.2 Product Outlook
13.5.3 Key Developments
13.6 Quest Diagnostics
13.6.1 Business Overview
13.6.2 Product Outlook
13.6.3 Key Developments
13.7 Myriad Genetics, Inc.
13.7.1 Business Overview
13.7.2 Product Outlook
13.7.3 Key Developments
13.8 Centogene
13.8.1 Business Overview
13.8.2 Product Outlook
13.8.3 Key Developments
13.9 Invitae Corporation
13.9.1 Business Overview
13.9.2 Product Outlook
13.9.3 Key Developments
13.10 GenPath
13.10.1 Business Overview
13.10.2 Product Outlook
13.10.3 Key Developments
13.11 PerkinElmer
13.11.1 Business Overview
13.11.2 Product Outlook
13.11.3 Key Developments
13.12 Agilent Technologies
13.12.1 Business Overview
13.12.2 Product Outlook
13.12.3 Key Developments
14. APPENDIX
14.1 About DPI Research
14.2 Glossary of Terms
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. UNITED STATES ACTUAL NON–INVASIVE PRENATAL TESTING VOLUME (NUMBER OF TESTS PERFORMED) AND FORECAST (2019 - 2031)
4.1 Average Risk Actual NIPT Test Volume (Number of Tests Performed) and Forecast
4.2 High-Risk Actual NIPT Test Volume (Number of Tests Performed) and Forecast
5. UNITED STATES POTENTIAL NON–INVASIVE PRENATAL TESTING VOLUME (NUMBER OF TESTS PERFORMED) AND FORECAST (2019 - 2031)
5.1 Average Risk Potential NIPT Test Volume (Number of Tests Performed) and Forecast
5.2 High-Risk Potential NIPT Test Volume (Number of Tests Performed) and Forecast
6. UNITED STATES ACTUAL NON–INVASIVE PRENATAL TESTING MARKET SIZE AND FORECAST (2019 - 2031)
6.1 Average Risk Actual NIPT Test Market Size and Forecast
6.2 High-Risk Actual NIPT Test Market Size and Forecast
7. UNITED STATES POTENTIAL NON–INVASIVE PRENATAL TESTING MARKET SIZE AND FORECAST (2019 - 2031)
7.1 Average Risk Potential NIPT Test Market Size and Forecast
7.2 High-Risk Potential NIPT Test Market Size and Forecast
8. UNITED STATES NON–INVASIVE PRENATAL TESTING MARKET GROWTH DRIVERS AND CHALLENGES
8.1 Key Market Growth Drivers
8.2 Key Market Challenges
9. NON–INVASIVE PRENATAL TESTING COMPARATIVE ANALYSIS
10. REIMBURSEMENT ENVIRONMENT OF THE UNITED STATES NON-INVASIVE PRENATAL TESTING
11. REGULATION FRAMEWORK OF THE UNITED STATES NON-INVASIVE PRENATAL TESTING
12. MAJOR DEALS AND AGREEMENTS IN THE NON–INVASIVE PRENATAL TESTING MARKET
12.1 Collaboration Deals
12.2 Venture Capital Investment
12.3 Mergers and Acquisitions
12.4 Exclusive Agreement
12.5 Licensing Agreement
12.6 Distribution Agreement
12.7 Partnership Deals
13. KEY COMPANIES ANALYSIS
13.1 Laboratory Corporation of America Holdings
13.1.1 Business Overview
13.1.2 Product Outlook
13.1.3 Key Developments
13.2 Yourgene Health
13.2.1 Business Overview
13.2.2 Product Outlook
13.2.3 Key Developments
13.3 Ariosa Diagnostics (Roche)
13.3.1 Business Overview
13.3.2 Product Outlook
13.3.3 Key Developments
13.4 Illumina, Inc.
13.4.1 Business Overview
13.4.2 Product Outlook
13.4.3 Key Developments
13.5 Natera,Inc.
13.5.1 Business Overview
13.5.2 Product Outlook
13.5.3 Key Developments
13.6 Quest Diagnostics
13.6.1 Business Overview
13.6.2 Product Outlook
13.6.3 Key Developments
13.7 Myriad Genetics, Inc.
13.7.1 Business Overview
13.7.2 Product Outlook
13.7.3 Key Developments
13.8 Centogene
13.8.1 Business Overview
13.8.2 Product Outlook
13.8.3 Key Developments
13.9 Invitae Corporation
13.9.1 Business Overview
13.9.2 Product Outlook
13.9.3 Key Developments
13.10 GenPath
13.10.1 Business Overview
13.10.2 Product Outlook
13.10.3 Key Developments
13.11 PerkinElmer
13.11.1 Business Overview
13.11.2 Product Outlook
13.11.3 Key Developments
13.12 Agilent Technologies
13.12.1 Business Overview
13.12.2 Product Outlook
13.12.3 Key Developments
14. APPENDIX
14.1 About DPI Research
14.2 Glossary of Terms
LIST OF FIGURES:
Figure 2 1: United States Actual NIPT Test Volume (Thousand),2019 – 2022
Figure 2 2: United States Actual NIPT Test Volume Forecast (Thousand),2023 – 2031
Figure 2 3: United States Average Risk Actual NIPT Test Volume (Thousand),2019 – 2022
Figure 2 4: United States Average Risk Actual NIPT Test Volume Forecast (Thousand),2023 – 2031
Figure 2 5: United States High-Risk Actual NIPT Test Volume (Thousand),2019 – 2022
Figure 2 6: United States High-Risk Actual NIPT Test Volume Forecast (Thousand),2023 – 2031
Figure 3 1: United States Potential NIPT Test Volume (Thousand),2019 – 2022
Figure 3 2: United States Potential NIPT Test Volume Forecast (Thousand),2023 – 2031
Figure 3 3: United States Average Risk Potential NIPT Test Volume (Thousand),2019 – 2022
Figure 3 4: United States Average Risk Potential NIPT Test Volume Forecast (Thousand),2023 – 2031
Figure 3 5: United States High-Risk Potential NIPT Test Volume (Thousand),2019 – 2022
Figure 3 6: United States High-Risk Potential NIPT Test Volume Forecast (Thousand),2023 – 2031
Figure 4 1: United States Actual NIPT Test Market Size (Million US$),2019 – 2022
Figure 4 2: United States Actual NIPT Test Market Size Forecast (Million US$),2023 – 2031
Figure 4 3: United States Average Risk Actual NIPT Test Market Size (Million US$),2019 – 2022
Figure 4 4: United States Average Risk Actual NIPT Test Market Size Forecast (Million US$),2023 – 2031
Figure 4 5: United States High-Risk Actual NIPT Test Market Size (Million US$),2019 – 2022
Figure 4 6: United States High-Risk Actual NIPT Test Market Size Forecast (Million US$),2023 – 2031
Figure 5 1: United States Potential NIPT Test Market Size (Million US$),2018 – 2021
Figure 5 2: United States Potential NIPT Test Market Size Forecast (Million US$),2022 – 2030
Figure 5 3: United States Average Risk Potential NIPT Test Market Size (Million US$),2019 – 2022
Figure 5 4: United States Average Risk Potential NIPT Test Market Size Forecast (Million US$),2023 – 2031
Figure 5 5: United States High-Risk Potential NIPT Test Market Size (Million US$),2019 – 2022
Figure 5 6: United States High-Risk Potential NIPT Test Market Size Forecast (Million US$),2023 – 2031
Figure 2 1: United States Actual NIPT Test Volume (Thousand),2019 – 2022
Figure 2 2: United States Actual NIPT Test Volume Forecast (Thousand),2023 – 2031
Figure 2 3: United States Average Risk Actual NIPT Test Volume (Thousand),2019 – 2022
Figure 2 4: United States Average Risk Actual NIPT Test Volume Forecast (Thousand),2023 – 2031
Figure 2 5: United States High-Risk Actual NIPT Test Volume (Thousand),2019 – 2022
Figure 2 6: United States High-Risk Actual NIPT Test Volume Forecast (Thousand),2023 – 2031
Figure 3 1: United States Potential NIPT Test Volume (Thousand),2019 – 2022
Figure 3 2: United States Potential NIPT Test Volume Forecast (Thousand),2023 – 2031
Figure 3 3: United States Average Risk Potential NIPT Test Volume (Thousand),2019 – 2022
Figure 3 4: United States Average Risk Potential NIPT Test Volume Forecast (Thousand),2023 – 2031
Figure 3 5: United States High-Risk Potential NIPT Test Volume (Thousand),2019 – 2022
Figure 3 6: United States High-Risk Potential NIPT Test Volume Forecast (Thousand),2023 – 2031
Figure 4 1: United States Actual NIPT Test Market Size (Million US$),2019 – 2022
Figure 4 2: United States Actual NIPT Test Market Size Forecast (Million US$),2023 – 2031
Figure 4 3: United States Average Risk Actual NIPT Test Market Size (Million US$),2019 – 2022
Figure 4 4: United States Average Risk Actual NIPT Test Market Size Forecast (Million US$),2023 – 2031
Figure 4 5: United States High-Risk Actual NIPT Test Market Size (Million US$),2019 – 2022
Figure 4 6: United States High-Risk Actual NIPT Test Market Size Forecast (Million US$),2023 – 2031
Figure 5 1: United States Potential NIPT Test Market Size (Million US$),2018 – 2021
Figure 5 2: United States Potential NIPT Test Market Size Forecast (Million US$),2022 – 2030
Figure 5 3: United States Average Risk Potential NIPT Test Market Size (Million US$),2019 – 2022
Figure 5 4: United States Average Risk Potential NIPT Test Market Size Forecast (Million US$),2023 – 2031
Figure 5 5: United States High-Risk Potential NIPT Test Market Size (Million US$),2019 – 2022
Figure 5 6: United States High-Risk Potential NIPT Test Market Size Forecast (Million US$),2023 – 2031
LIST OF TABLES:
Table 6 1: Maternal Age at Delivery and Risk of Down Syndrome
Table 7 1: Non–Invasive Prenatal Testing – Comparative Tests Analysis
Table 10 1: Collaboration Deals in the Non–Invasive Prenatal Testing Market
Table 10 2: Venture Capital Investment in the Non–Invasive Prenatal Testing Market
Table 10 3: Merger & Acquisition in the Non–Invasive Prenatal Testing Market
Table 10 4: Exclusive Agreement in the Non–Invasive Prenatal Testing Market
Table 10 5: Licensing Agreement in the Non–Invasive Prenatal Testing Market
Table 10 6: Distribution Agreement in the Non–Invasive Prenatal Testing Market
Table 10 7: Partnership Deals in the Non–Invasive Prenatal Testing Market
Table 6 1: Maternal Age at Delivery and Risk of Down Syndrome
Table 7 1: Non–Invasive Prenatal Testing – Comparative Tests Analysis
Table 10 1: Collaboration Deals in the Non–Invasive Prenatal Testing Market
Table 10 2: Venture Capital Investment in the Non–Invasive Prenatal Testing Market
Table 10 3: Merger & Acquisition in the Non–Invasive Prenatal Testing Market
Table 10 4: Exclusive Agreement in the Non–Invasive Prenatal Testing Market
Table 10 5: Licensing Agreement in the Non–Invasive Prenatal Testing Market
Table 10 6: Distribution Agreement in the Non–Invasive Prenatal Testing Market
Table 10 7: Partnership Deals in the Non–Invasive Prenatal Testing Market
